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ABSTRACT
Among the various types of DNA damage, inter-
strand cross-links (ICL) represent one of the most
cytotoxic lesions. Processes such as transcription
and replication can be fully blocked by ICLs, as
shown by the mechanism of action of some anti-
cancer drugs. However, repair of ICLs can be a pos-
sible cause of resistance. To study the mechanisms
of cross-link repair stable, site-specifically cross-
linked duplexes are needed. We here report on the
synthesis of site-specifically cross-linked DNA using
an acyclic furan containing nucleoside. Selective
in situ oxidation of the incorporated furan moiety
generates a highly reactive oxo-enal that instantly
reacts with the complementary base in a non-
modified strand, yielding one specific stable cross-
linked duplex species. Varying sequence context
showed that a strong selectivity for cross-linking
to either complementary A or complementary C is
operating, without formation of cross-links to neigh-
boring or distant bases. Reaction times are very
short and high isolated yields are obtained using
only one equivalent of modified strand. The formed
covalent link is stable and the isolated cross-linked
duplexes can be stored for several months without
degradation. Structural characterization of the
obtained ICL was possible by comparison to the
natural mutagenic adducts of cis-2-butene-1,4-dial,
a metabolite of furan primarily responsible for furan
carcinogenicity.
INTRODUCTION
Interstrand cross-link (ICL) forming agents are frequently
used in cancer treatment but it has been shown that
resistance can arise by the action of repair enzymes that
can repair the induced lesions in tumor cells (1,2). The
mechanism by which ICLs are repaired in mammalian
cells is still unknown, and only hypothetical models exist
to date (3). Knowledge about formation and repair of
ICLs should help to understand the clinical eﬀectiveness
and side-eﬀects of these agents and possibly help to
improve cytostatic therapy (4). The study of ICL repair
is hampered by the diﬃculty of producing suitable sub-
strates for the mechanistic studies: as the ICLs only
represent a minor fraction of all lesions it is impossible
to extract one speciﬁc cross-linked sequence from biolog-
ical material. Therefore, considerable research eﬀort has
been invested in synthesizing short cross-linked oligonu-
cleotide duplexes as model substrates often based on the
use of reactive oligonucleotides (5,6). The most recent
mechanistic investigations on cross-link repair rely on
ligation of synthetically and site-speciﬁcally generated
short cross-linked oligonucleotides which are incorpo-
rated into plasmids, emphasizing the need for chemical
methods for high-yielding and deﬁned oligonucleotide
ICL formation (3).
ICL-forming oligonucleotides further ﬁnd widespread
application in other chemical biology research areas. In
the antisense area, oligonucleotides that can induce cova-
lent bond formation with the target mRNA, ensure tighter
binding than traditional steric block sequences. They
incorporate a functional moiety that may cause irrevers-
ible damage to the target sequences and inhibition of the
elongation step has been achieved by the use of such active
antisense strands (7). It has further been suggested that
active oligonucleotides make RNase H activity superﬂu-
ous (8,9). Not only do cross-links impose continuous
double strand formation, they could also have an inﬂuence
on the overall duplex structure. Double-stranded decoy-
DNA can bind with high aﬃnity to target transcription
factors thereby altering gene transcription as the transcrip-
tion factor is occupied by the decoy (10). Transfection of
cells with this double-stranded DNA has been shown to
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stability of the decoy DNA, one of the strategies used is to
introduce an ICL in the double-stranded DNA (12). It has
further been postulated that the cross-links have the
potential of constraining the oligonucleotide in a form
that is more active towards the transcription factor (13).
Construction of oligonucleotides with a functional
moiety that is reactive toward the complementary strand
has been achieved in various ways. Alkylating moieties
have been proposed for this purpose but can suﬀer from
lack of speciﬁcity in the reaction or tend to be unstable
under physiological conditions (3,14–16). Therefore, the
idea of using stable precursors with inducible reactivity
was proposed as a possible solution to this problem.
Next to the concept of photo cross-linking (17–20), more
recently novel concepts of inducible reactivity have been
proposed based on phenyl sulﬁde (21,22) and phenyl sele-
nide (23,24) derivatives.
On the basis of this idea of inducible reactivity, we
recently developed a new complementary methodology
for DNA cross-linking based on the incorporation and
subsequent in situ selective oxidation of a furan-modiﬁed
nucleoside building block (25). In order to explore the full
capacity and sequence selectivity of the furan-oxidation-
cross-link strategy we recently synthesized a simpliﬁed,
acyclic building block (26). We here describe the use of
this new acyclic furan containing building block and
report upon the exploration of the sequence selectivity
of the proposed method. We furthermore have been able
to show that a new type of adduct is formed within this
series of cross-linked duplexes. Structural characterization
of the formed cross-linked adducts was possible by con-
sidering the earlier described mechanisms of formation
of naturally occurring nucleoside and single-stranded
oligonucleotide adducts generated through reaction
with frequently occurring furan or lipid peroxidation
metabolites.
MATERIALS AND METHODS
All solvents and chemical reagents were purchased from
Sigma-Aldrich in the highest purity available. Products
for DNA synthesis were obtained from Glen Research.
Exonuclease III was purchased from GE Healthcare.
IR spectra were recorded on a Perkin Elmer 1600 series
FTIR-spectrometer. IR intensities are reported as strong
(s) or medium (m). Optical rotations were measured on
a Perkin Elmer 241 polarimeter.
1H NMR and
13C NMR
spectra were recorded on a Bruker Avance 300 or a
Bruker DRX 500 spectrometer operating at room
temperature. Chemical shifts are reported in parts per
million (d) relative to the residual solvent peak.
Multiplicities are reported as singlet (s), broad singlet
(bs), doublet (d), doublet of doublets (dd), triplet (t)
or multiplet (m). Purities of small compounds were
checked by RP–HPLC–MS (Agilent-1100 series LC/MS
system) equipped with a Phenomenex Luna C18 column
(250 4.6mm, 5mma t3 5 8C). The used solvent system
was 5mM NH4OAC in water (A) and MeCN (B).
The used gradient went from 0 to 100% B in 15min.
All RP–HPLC experiments with oligonucleotides were
recorded on an Agilent 1100 system equipped with a
Phenomenex Jupiter 300A ˚ C18 column (250 4.6mm,
5mma t5 0 8C) with 0.1M TEAA (with 5% MeCN) and
MeCN as mobile phases (linear gradient: 0–30% MeCN in
15min). Mass spectra of oligonucleotides were recorded
on an ABI Voyager DE–STR MALDI–TOF in positive
mode with 3-HPA and ammonium citrate as matrix.
Samples were desalted with DOWEX as described else-
where (27). Oligonucleotides were synthesized DMT-on
on an ABI 394 DNA synthesizer. Sep-pak C18 cartridges
were obtained from Waters.
(S)-Toluene-4-sulfonic acid 2-(2,2-dimethyl-[1,3]dioxo-
lan-4-yl)-ethyl ester 5. S-(+)-3,4-o-isopropylidenedioxy-
butan-1-ol 4 (1.730g, 11.849mmol, 1 eq.) was weighed
in a two-neck ﬂask. Extra dry pyridine (1.5ml) was
added followed by paratoluenesulfonylchloride (2.589g,
13.6mmol, 1.15 eq.) in one portion and the ﬂask was
ﬂushed with argon. After a couple of minutes a white sus-
pension forms. After 2.5h the mixture is poured into 3ml
aqueous 1M HCl solution followed by extraction with
diethylether. The organic phase was washed three times
with a 1M aqueous HCl solution and three times with
saturated NaHCO3 solution. The organic layer was
dried over anhydrous Na2SO4 and evaporated under
reduced pressure. The obtained colourless oil (3.247g,
10.82mmol, 91%) can be used for further reactions with-
out puriﬁcation. ESI–MS (M + Na
+): 323,0; Retention
time: 17.0min; IR (cm
 1): 3448 (b), 1598 (m), 1361 (s),
1189 (s), 1177;
1H NMR (300MHz, CDCl3): d 7.80 (d,
2H, J=8.27), 7.35 (d, 2H, J=8.1), 3.85–4.10 (m, 3H),
3.51 (dd, 2H, J=7.87, 6.94), 2.45 (s, 3H), 1.92 (m, 2H),
1.34 (s, 3H), 1.29 (s, 3H);
13C NMR (75MHz, CDCl3): d
144.87, 132.98, 129.81, 127.94, 109.06, 72.32, 69.10, 67.42,
33.17, 26.86, 25.56, 19.05.
(S)-4-(2-Bromo-ethyl)-2,2-dimethyl-[1,3]dioxolane 6.
Tosylate 5 (1.990g, 6.63mmol, 1 eq.) was dissolved in
extra dry DMF (10ml) before adding anhydrous LiBr
(2.540g, 33mmol, 5 eq.) to the mixture. The reaction mix-
ture was slowly heated to 608C until all the LiBr was
dissolved. After 1h the reaction mixture was poured into
ice water. The aqueous phase was extracted three times
with diethyl ether, the combined organic phases were col-
lected and washed with water and saturated NaHCO3
solution. The organic layer was dried over anhydrous
NaSO4 ﬁltered and evaporated under reduced pressure.
The obtained crude was puriﬁed by ﬂash chromatography
(EtOAc/pentane 1:5). Compound 6 was co-evaporated
with extra dry THF before use in the next reaction. Rf
(3:2 pentane: EtOAc) 0.7; IR(cm
 1): 1370 (s), 1252 (s),
1214 (s), 1152 (m), 1062 (s), 847 (m), 515 (m);
1H NMR
(300MHz, CDCl3): d 4.25 (m, 1H), 4.08 (dd, 1H, J=6.85,
7.31), 3.57 (dd, 1H, J=6.23, 7.98), 3.48 (m, 2H), 2.08
(m, 2H), 1.39 (s, 3H), 1.34 (s, 3H);
13C NMR (75MHz,
CDCl3): d 109.15, 74.00, 68.92, 37.11, 29.42, 26.99, 25.58.
(S)-4-(2-Furan-2-yl-ethyl)-2,2-dimethyl-[1,3]dioxolane
7.n -Buthyllithium (7.5ml of a 1.6M solution in hexanes,
1.8 eq.) was added to 6ml THF at  788C. Upon furan
addition (900mg, 13.25mmol, 2 eq.) a white precipitate
was formed. After 15min, the temperature was allowed to
rise to 08C. The mixture was left to stir for an additional
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the previous reaction) was added in one portion. The
mixture was stirred overnight, poured in ice water and
the product was extracted from the aqueous phase with
diethyl ether. The organic layer was dried over Na2SO4
before evaporation under reduced pressure. The product
was puriﬁed with ﬂash chromatography (pentane/EtOAc
10:1). The reaction resulted in 800mg (4.08mmol, 62%
over two steps) of the desired product. ESI–MS
(M-(CH3)2CO)
+: 139.1; Retention time = 17.0min;
[a]D
24 = +2.5 (c 0.061M, CHCl3);
1H NMR (300MHz,
CDCl3): d 7.26 (dd, 1H, J=0.61, 1.44), 6.23 (dd, 1H,
J=3.1, 1.9), 5.97 (dd, 1H, J=0.7, 3.1), 3.97 (dd, 1H,
J=6.0, 7.8), 3.74 (m, 1H), 3.48 (dd, 1H, J=7.4, 7.7),
2.69 (m, 2H), 1.86 (m, 2H), 1.38 (s, 3H), 1.31 (s, 3H);
13C NMR (75MHz, CDCl3): d 155.20, 141.00, 110.15,
108.81, 105.08, 75.25, 69.19, 32.08, 26.98, 25.89, 24.34.
(S)-4-Furan-2-yl-butane-1,2-diol 8. Protected diol 7
(309mg, 1.57mmol, 1 eq.) was dissolved in THF (3ml).
A 4M solution of HCl (1.5ml) was added under stirring
and external cooling with an ice bath. The reaction mix-
ture was allowed to stir at 08C for 3h. The product was
extracted from the reaction mixture with EtOAc and the
organic layer was concentrated under reduced pressure.
Traces of starting material could be removed by ﬂash
chromatography using a 1:1 mixture of pentane:EtOAc.
(S)-4-furan-2-yl-butane-1,2-diol was obtained in 89%
yield (220mg). ESI–MS(M+H
+): 157.1; retention time:
11.0min; [a]D
24 =  11.5 (c 0.025M,CHCl3), IR (cm
 1):
3385 (b), 1596 (m), 1508 (m);
1H NMR (300MHz,
CDCl3): d 7.26 (d, 1H, J=0.61), 6.24 (dd, 1H, J=1.9,
3.0), 5.98 (d, 1H, J=3.0), 3.67 (m, 1H), 3.59 (m, 1H), 3.41
(m, 1H), 3.21 (bs), 3.14 (bs), 2.73 (m, 2H), 1.73 (m, 2H);
13C NMR (75MHz, CDCl3): d 155.41, 141.02, 110.20,
105.14, 71.46, 66.60, 31.35, 24.10.
(S)-1-[bis-(4-Methoxy-phenyl)-phenyl-methoxy]-
4-furan-2-yl-butan-2-ol 9. The diol (212mg, 1.36mmol,
1 eq.) was co-evaporated three times with extra dry pyr-
idine and dissolved in extra dry pyridine (2ml).
Dimethoxytritylchloride (DMTCl) (460mg, 1.36mmol,
1 eq.) was added at 08C. After 1.25h MeOH (1ml) was
added and stirring continued for 10min. EtOAc was
added and the organic layer was washed three times
with saturated NaHCO3 solution. The organic layer
was dried over Na2SO4 and evaporated under reduced
pressure. The crude compound was puriﬁed by column
chromatography using 7:1 cyclohexane:EtOAc. Total
410mg of the mono-tritylated/compound was obtained
(0.90mmol, 66%). ESI–MS: 481.2 (M+Na
+); Retention
time: 19.7min; [a]D
24=4.7 (c 0.015M,CHCl3); IR (cm
 1):
3436 (b), 1607 (m), 1508 (s), 1249 (s), 1176 (s), 1034 (m);
1H NMR (300MHz, CDCl3): d 7.42 (m, 2H), 7.31
(m, 7H), 7.27 (m, 1H), 6.83 (d, 4H, J=6.15), 6.26
(dd, 1H, J=1.9, 3.0), 5.95 (d, 1H, J=3.12), 3.79
(bs, 7H), 3.17 (dd, 1H, J=3.3, 9.3), 3.05 (dd,
1H, J=7.4, 9.3), 2.71, m, 2H), 2.34 (d, 1H, J=3.48),
1.73 (m, 2H);
13C NMR (75MHz, CDCl3): d 158.37,
155.51, 144.60, 140.74, 135.82, 129.81, 127.99, 127.72,
126.70, 113.00, 109.94, 104.82, 85.98, 70.07, 67.23, 55.08,
31.15, 23.93.
Diisopropyl-phosphoramidous acid 1-[bis-(4-methoxy-
phenyl)-phenyl-methoxymethyl]-3-furan-2-yl-propyl ester
2-cyano-ethyl ester 3. The DMT protected nucleoside
(220mg, 0.48mmol, 1 eq.) was dissolved in dry CH2Cl2
(10ml). DIPEA (0.9ml, 0.70g, 5.4mmol, 11 eq.) was
added followed by 2-cyanoethyl N,N-diisopropylchloro-
phosphoramidite (284mg, 1.2mmol, 2.5 eq.). After 2h
no more changes in the reaction mixture were observed
by TLC and saturated NaHCO3 solution was added.
The product was extracted with CH2Cl2, dried over
NaSO4, ﬁltered and evaporated under reduced pressure.
The resulting oil was puriﬁed by column chromatography
using 7:1 cyclohexane:EtOAc. The phosphoramidite
(250mg, 0.38mmol, 79%) was obtained as colourless
oil. Rf (cyclohexane/EtOAc 7:1) 0.38; mass: 681.3
(M+Na
+);
31P NMR (121MHz): d 148.47, 149.26.
DNA synthesis and purification
All oligonucleotides were synthesized DMT-on on an
ABI 394 DNA/RNA synthesizer in 1mmol scales. A
standard synthesis protocol was used except for the mod-
iﬁed residues. These were coupled manually for 10min
with dicyano-imidazole (DCI) as activator instead of
tetrazole. All couplings were estimated to be over 99%.
Oligonucleotides were cleaved from solid support and
deprotected by incubation at 558C overnight in concen-
trated aqueous ammonia. The trityl groups were removed
with 1.5% aqueous TFA on sep-pak and the result-
ing oligonucleotides were puriﬁed by RP–HPLC.
Oligonucleotides 10–13 were obtained in this way. The
complements, oligonucleotides 14–29 were purchased
were purchased from Eurogentec Lie ` ge (see Table 1 for
speciﬁc sequences).
Thermaldenaturation experiments
All UV experiments were recorded on a Varian Cary 300
Bio equipped with a six-cell thermostatted cell holder.
Melting curves were monitored at 260nm with a heating
rate of 0.38C/min. The buﬀer contained 100mM NaCl
and 10mM phosphate buﬀer (pH 7). Oligonucleotide con-
centration was 2mM for each strand. Melting tempera-
tures were calculated from the ﬁrst derivative of the
heating curves using the Cary 300 Bio software.
Table 1. Synthesized modiﬁed sequences and purchased complementary
oligonucleotides
Modiﬁed sequences
10 50-CTGACG A2ATGC-30
11 50-CTGACG G2GTGC-30
12 50-CTGACG C2C TGC-30
13 50-CTGACG T2T TGC-30
Complements, N=
30-GAC TGC TNT ACG-50 AGCT
30-GAC TGC CNC ACG-50 14 15 16 17
30-GAC TGC GNG ACG-50 18 19 20 21
30-GAC TGC ANA ACG-50 22 23 24 25
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The modiﬁed strands were mixed with their complements
in equimolar amounts in 10mM phosphate buﬀer (pH 7)
and 100mM NaCl before annealing from 958C to room
temperature. Temperatures during the whole reaction
were kept constant in an Eppendorf thermomixer comfort
at 208C. A stock solution of NBS (1 eq./5ml) was freshly
prepared and to start the reaction, 1 eq. NBS was added.
This was repeated every 15min until complete disappear-
ance of the modiﬁed oligonucleotide. The reaction was
monitored by RP–HPLC. Reaction mixtures were concen-
trated in vacuo before preparative RP–HPLC puriﬁcation.
Enzymatic digestion
The puriﬁed cross-linked product (0.6 nmol) was dissolved
in 80ml water. Eight microlitres of the supplied 10  reac-
tion buﬀer was added and the mixture was heated till
378C. The enzyme (200 units) was added and the reaction
was shaken at 378C for 50min and directly injected into
the RP–HPLC to collect all oligonucleotide-like fractions.
All collected peaks were analysed by MALDI–TOF.
Gel-electrophoresis experiments
A 20% polyacrylamide with 1  TBE buﬀer was used for
all analyses. The temperature of the gel was stabilized
with a Julabo F12at 608C. The power supply used for
gel-electrophoresis was a consort EV202. Gels were
stained with GelRed (VWR) and pictures were taken
with an Autochemi imaging system (UVP).
RESULTS AND DISCUSSION
The furan-oxidationstrategy asanew method for
cross-linking
Furan is an industrially important chemical found in food
and cigarette smoke (28). Studies have demonstrated that
the DNA damage that is responsible for the mutagenicity
and possibly the carcinogenicity of furan is caused by an
oxidation product, the cis-2-butene-1,4-dial. This principle
of converting a stable aromatic moiety into a reactive
aldehyde formed the basis of our new approach.
Selective oxidation of the incorporated furan moiety gen-
erates a reactive 4-oxo-enal derivative that reacts instan-
taneously with the complementary strand, yielding a
cross-linked duplex species as characterized by ESI–MS
(25). Preliminary studies with the ﬁrst generation of
furan-modiﬁed oligonucleotides indicated the formation
of an imine derivative generated by attack of an exocyclic
aminogroup onto the aldehyde functionality, however no
ﬁrm proof as to the nature of the covalent link was
obtained (Figure 1).
Designof asimplified furan-containing building block
Our ﬁrst generation furan-modiﬁed building blocks 1
involved conjugation of the furan moiety to 20-amino
nucleosides via an amide bond (Figure 2). Synthesis
required the 20-amino uridine derivatives which served
to attach the desired furan moiety via an amide bond.
In order to fully explore the sequence selectivity of the
furan-oxidation cross-link methodology in terms of inﬂu-
ence of complementary and neighbouring bases and to
structurally identify the type of covalent bond formed,
we needed easy access to larger quantities of modiﬁed
nucleoside building block. A new acyclic building block
2 was developed featuring a simple acyclic backbone
where the base was replaced by the desired furan moiety.
The synthetic route towards the desired phosphorami-
dite 3 for incorporation into oligonucleotides is short
and easily scalable (Figure 3). Starting from the com-
mercially available S-(+)-3,4-O-isopropylidenedioxy-
butan-1-ol, tosylation in pyridine was immediately
followed by conversion to the bromide without intermedi-
ate puriﬁcation. Treatment with lithium bromide in DMF
yields bromide 6 which needs to be puriﬁed by chromato-
graphy. This bromide can be easily substituted by lithiated
furan to generate the skeleton of the target nucleoside 2.
Using a 4M HCl solution in THF at low temperature led
to deprotection without side reactions at the furan level. In
the subsequent treatment with DMTCl the selectivity for
monotritylation can be increased by working at low tem-
perature and the small amount of ditritylated compound
can be easily separated by chromatography. Conversion
into the desired phosphoramidite 3 was performed under
standard conditions.
Preparation of furan-containing oligonucleotides
Exploration of the cross-link selectivity being one of our
goals, 3 was incorporated into four diﬀerent sequences
O
O
O
2
2′
NH
O
O N
O
HN O
O
1a 2′ R
1b 2′ S
O
O
Figure 2. First- and second-generation furan-modiﬁed nucleoside build-
ing blocks.
O
O O
5′
3′ 3′
5′
3′
5′
5′
3′
5′
3′
5′
3′
oxidation
Furan-modified
oligonucleotide
4-oxo-enal derivative interstrand
cross-link
Figure 1. The furan-oxidation cross-linking strategy.
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Table 2). Oligonucleotide masses were conﬁrmed using
MALDI–TOF MS (Supplementary Data).
The inﬂuence of incorporated 2 on duplex stability was
evaluated. Varying the opposing base in the complemen-
tary strand leads to 16 possible duplexes that were studied.
As expected a severe drop in stability can be observed
(Table 2). Reported losses in stability upon incorporation
of acyclic nucleoside analogues range from 38C (29) to
158C (30). Since these values refer to cases where the nat-
ural bases are still present, it is not surprising to see that
destabilization caused by 2 is higher, reﬂecting the addi-
tional loss of hydrogen bonding and stacking interactions.
Cross-linking experiments: determination ofcross-linking
complementary bases
Assessment of the capacity of diﬀerent opposing bases
included in the complementary strand to cross-link
to the oxidized furan moiety was conducted using oligo-
nucleotide 10. Since in this case the furan-containing 2
is ﬂanked by two A residues, the complementary strand
will contain two T residues ﬂanking the complemen-
tary base N (Figure 4A). In view of the non-reactivity
of T towards oxidation products of furan (28), duplexes
with 10 as modiﬁed strand allow evaluating which
bases situated exactly opposite 2 will lead to cross-linked
duplex.
Cross-linking experiments were conducted after anneal-
ing 10 to complementary oligonucleotides 14–17 using 1
eq. of both modiﬁed and complementary strand. A freshly
prepared N-bromosuccinimide (NBS) solution was added
for the in situ oxidation of the furan unit and the resulting
reaction mixture was analysed by 20% denaturing PAGE
and RP–HPLC (Figure 4B, C and D). As in the case of the
ﬁrst generation furan-modiﬁed oligonucleotides, cross-
linking takes place immediately upon NBS addition. In
this case, after addition of maximum 3 eq. of NBS, con-
sumption of the modiﬁed strand was completed and a new
species was formed. The new slower running species on
PAGE and RP–HPLC was shown by MALDI–TOF MS
to have a mass consistent with the sum of the masses of the
oxidized and complementary strand. Both A and C com-
plementary bases give rise to eﬃcient cross-link formation
while T and G do not. RP–HPLC spectral analysis shows
that in case of a complementary G (Figure 4D), the mod-
iﬁed strand is completely consumed but no clear peak
corresponding to a cross-linked product can be observed,
consistent with the PAGE data. This observed selectivity
for A and C contrasts with the earlier observation
that aldehydes such as acrolein and crotonaldehyde,
which have been shown by others to arise endogenously
in mammalian cells, form preferably guanine adducts in
the DNA of these cells (31,32). Furthermore, inter-chain
cross-linking with these reagents has been investigated
and shown to give rise to G-G cross-links (33,34). On
the other hand, cis-2-butene-1,4-dial has been shown
to form mutagenic adducts with three out of the four
nucleosides 20-deoxycytidine, 20-deoxyadenosine and
20-deoxyguanosine but no cross-linked duplexes directly
resulting from treatment with this furan metabolite
have been described (28). In the currently studied cross-
linking context, where the furan has been ﬁxed to one of
the oligonucleotide strands in the duplex, the observed
O
O OH
O
O OTs
O
O Br
O
O
O
HO
HO
O
RO
O
(a) (b) (c)
(d) (e)
9 R = H 
3 R= P(NiPr2)O(CH2)2CN 
(f)
45 6
78
DMTrO
Figure 3. Synthesis of acyclic furan containing building block 3. Reagents and conditions: (a) pTsCl (1.15 eq.), pyridine, 08C, 2.5h, 91%; (b) LiBr
(5 eq.), DMF, 608C, 1h; (c) Furan (2 eq.), BuLi (1.8 eq.), THF, 78 to 08C, 16h, 62% over two steps; (d) 4M HCl, THF, 3h, 08C, 89%; (e) DMTCl
(1 eq.), pyridine, 08C, 1.25h, 66%; (f) (iPr2N)(NCCH2CH2O)PCl (2.5 eq.), DIPEA, CH2Cl2, 1.5h, rt, 79%.
Table 2. Melting temperatures in 8C for modiﬁed versus non-modiﬁed duplexes
Complementary base 2
 A 2
 C 2
 T 2
 G
10 50-CTGACG A2ATGC-30 30.9 ( 17.2) 24.0 ( 28.0) 30.0 (–19.7) 29.3 ( 24.1)
11 50-CTGACG G2GTGC-30 40.1 ( 16.6) 39.6 ( 19.7) 36.1 ( 17.0) 38.9 ( 23.5)
12 50-CTGACG C2C TGC-30 30.5 ( 23.2) 24.9 ( 36.7) 32.5 ( 23.8) 32.4 ( 26.3)
13 50-CTGACG T2T TGC-30 29.2 ( 20.5) 23.1 ( 30.4) 27.3 ( 19.9) 26.5 ( 25.2)
Melting curves were recorded at 260nm with a heating rate of 0.38C/min. Oligonucleotide concentrations were 2mM of each strand in 100mM NaCl
and 10mM phosphate buﬀer at pH. Values between parentheses refer to destabilization with respect to unmodiﬁed duplexes.
Nucleic Acids Research,2009, Vol.37, No. 5 1559selectivity for cross-linking to A and C can be possibly
explained in terms of a major groove location of the
furan moiety and/or its oxidized form (a molecular
model, showing the proximity of the base functionalities
to the oxidized furan moiety is included in the
Supplementary Data).
Site-specific ICLformation
Whereas in an A2A:TNT context ICL to N-ﬂanking bases
can be completely excluded, this is not the case in
sequences containing either A, C or G as N-ﬂanking resi-
dues. Analysis of the complete series of duplexes however,
indicated formation of mainly one single cross-linked
species in all cases as derived from PAGE (Figure 5)
and RP–HPLC analysis (Supplementary Data). With
all four modiﬁed strands fast and eﬃcient cross-linking
is generally observed to A and C complementary bases
(odd numbered lanes) and not to G and T (even numbered
lanes). One exception can be noticed in the C2C:GTG
context (lane 8) where a small spot can be observed
at the ICL level. The isolated species was shown to
have a mass consistent with a cross-linked duplex
(Supplementary Data). Surprisingly, in a C2C:GGG con-
text (lane 6) cross-linking was not observed. The minor
groove located exocyclic amine of G has been previously
shown to react with cis-2-butene-1,4-dial. This might seem
to contrast with the assumed major groove orientation of
the furan moiety (as derived from the A/C selectivity). In
the speciﬁc case of GTG, duplex conformation might
allow for the oxo-enal to be temporarily exposed to the
only available nucleophile being the minor groove located
N
2 of one of the ﬂanking G residues. The bulkiness of the
complementary G in the latter case presumably prevents
the furan moiety from reaching the minor groove.
Moreover, it has been recently shown that crosslinking
to abasic sites (with generation of an aldehyde in the
major groove) also occurs via reaction of the exocyclic
N
2-amino group of an opposing guanine (35).
Whereas 20-deoxyguanosine- and 20-deoxyadenosine-
cis-2-butene-1,4-dial adducts are substantially unstable
under physiological conditions and only the correspond-
ing 2-deoxycytidine adducts have a prolonged half-life, all
our cross-linked duplexes have shown to be stable showing
no degradation when stored for several months. Thermal
stability of the diﬀerent cross-linked duplexes was further
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Figure 4. (A) Schematic representation of the cross-link reaction; furan-containing oligonucleotide 10 was annealed to complementary oligonucleo-
tides 14–17 (14: N=A; 15: N=G; 16: N=C; 17: N=T) after which NBS was gradually added. (B) ICL formation was analysed by 20%
denaturing PAGE. Yields of isolated cross-linked duplexes are indicated above the gel. (C) RP–HPLC chromatograms ( =260nm) before (Ia)
and after (Ib) cross-link reaction with NBS for duplex 10 (CTGACGA2ATGC):14 (GACTGCTATACG). (D) RP–HPLC chromatograms
( =260nm) before (IIa) and after (IIb) cross-link reaction with NBS for duplex 10 (CTGACGA2ATGC):15 (GACTGCTGTACG).
1560 Nucleic Acids Research, 2009, Vol. 37,No. 5analysed by UV-melting experiments. A representative
graph concerning duplex 11:18 is shown in Figure 6.
Previous analysis showed that the modiﬁed duplex (left
curve in Figure 6, open circle) is quite strongly destabilized
compared to the non-modiﬁed duplex (middle curve in
Figure 6, open triangle). The melting proﬁle of the cross-
linked duplex, puriﬁed from the reaction mixture by
RP–HPLC, is represented by the curve on the right in
Figure 6 (open square). Whereas the introduction of the
modiﬁcation leads to a destabilization of 168C, the cross-
linking reaction increases duplex stability with more
than 288C compared to the unmodiﬁed reference duplex
or 448C when comparing to modiﬁed duplex. This steep
increase is seen for all cross-linked duplexes (Table 3).
In order to conﬁrm site-speciﬁc formation of only one
cross-linked species and to further exclude cross-linking to
neighbouring bases, enzymatic degradation studies were
performed on all isolated cross-linked duplexes. Figure 7
shows the RP–HPLC spectrum obtained after enzymatic
digestion of the cross-linked duplex 11:20 containing a
G2G/CCC context, using Exonuclease III. This speciﬁc
example was chosen in order to illustrate that also in
this case we were able to unambiguously determine the
complementary C to be the site of cross-linking and not
one of the neighbouring C residues.
As evidenced by the analysis in Figure 7 the enzyme
digests the modiﬁed strand up to two bases before
the location of the modiﬁed residue. As for the non-mod-
iﬁed strand, after 50min, next to digestion resulting
in product 30 containing the extra C-residue from the
complementary strand, fragment 31 is isolated with
a mass consistent with the only partially digested
modiﬁed strand cross-linked to a partially digested
complementary strand. The presence of this speciﬁc
ss
ICL
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complementary base:   A G  C T     A G   C  T   A   G   C T  A  G   C   T
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10: 5′-CTG ACG A2A TGC-3′
14-17: 3′-GAC TGC TNT ACG-5′
11: 5′-CTG ACG G2G TGC-3′
18-21: 3′-GAC TGC CNC ACG-5′
12:   5′-CTG ACG C2C TGC-3′
22-25: 3′-GAC TGC GNG ACG-5′
13:   5′-CTG ACG T2T TGC-3′
26-29: 3′-GAC TGC ANA ACG-5′
with N = A, G, C, T respectively
Figure 5. PAGE analysis of cross-linking experiments with all duplexes. Duplex combinations are depicted above. The speciﬁc modiﬁed strand used
(10–13) is indicated above the gel. Just below, indication is given of the speciﬁc opposing base in each complementary strand (14–29) and the last line
gives yields of cross-linked duplexes after isolation and puriﬁcation.
Figure 6. Comparison of melting curves for reference non-modiﬁed
duplex (GTG/CAC), modiﬁed duplex (G2G/CAC) and cross-linked
(G2G/CAC XL) duplex containing strands 11 and 18. Melting curves
were recorded at 260nm with a heating rate of 0.38C/min. Duplex
concentration was 2mM in 100mM NaCl and 10mM phosphate
buﬀer at pH 7.
Table 3. Melting temperatures of the cross-linked duplexes as derived
from the corresponding melting curves
Cross-linking strands Cross-linked
to A
Cross-linked
to C
10:5 0-CTG ACG A2A TGC-30 >848C 71.58C
11:5 0-CTG ACG G2G TGC-30 >848C 80.08C
12:5 0-CTG ACG C2C TGC-30 >848C >848C
13:5 0-CTG ACG T2T TGC-30 79.58C 79.08C
Melting temperatures for half of the samples cannot accurately be
determined since at 958C the plateau representing the single strands is
not reached for these duplexes and calculation of the ﬁrst derivative is
not possible. These melting temperatures are estimated to be higher
than 848C.
Nucleic Acids Research,2009, Vol.37, No. 5 156150-tail unambiguously indicates the exact position of the
cross-link.
Structural characterization of theformed covalentadduct
The basic idea behind the current cross-linking strategy is
the use of furan as masked reactive enal functionality. In
preliminary studies where we reported on the results of
this type of cross-linking reaction using 20-amide modiﬁed
furan derivatives 1, no exact structure determination was
possible (Stevens,K., Petersen,M. and Madder,A., unpub-
lished results).
Oxidation of the furan moiety in our modiﬁed oligonu-
cleotides leads to the generation of a 4-oxo-enal. This
species structurally resembles C40-oxidized abasic sites
(C4-AP), lesions that are commonly formed in high
yields by the antitumor agent, bleomycin. As was very
recently shown (36,37), ICLs can be attributed to this
type of lesion, involving attack of a 50 neighbouring ade-
nine in the complementary strand onto the free aldehyde.
Moreover, it was suggested that the ab-unsaturated alde-
hyde, generated by endonuclease III catalysed treatment
of C4-AP containing duplexes, could be an intermediate in
the ICL formation (Figure 8).
In the current work, cross-linked duplexes formed
through use of the new acyclic building block 2 led to
adducts that survived the acidic MALDI–TOF conditions
well. The observed mass via MALDI is consistent with
mere addition of both oligonucleotides without loss of
H2O. In earlier studies by Dedon (38) and Peterson (28)
the adducts formed by dC, dA and dG with furan
metabolite cis-2-butene-1,4-dial have been completely
characterized. A general reaction mechanism was
proposed involving initial reaction of the C1 atom of
cis-2-butene-1,4-dial with the exocyclic nitrogen atom of
the nucleosides (N
4 of dC, N
2 of dG and N
6 of dA). This
event is followed by the 1,4-addition of the adjacent endo-
cyclic nitrogen atom (N3 of dC, N1 of dG and dA) to the
double bond of the remaining ab-unsaturated aldehyde
and subsequent attack of the alcohol on the second alde-
hyde group to form the ﬁnal product (Figure 9, pathways
a + b).
As for the exact structure of the formed adducts, we
propose that after initial attack of the exocylic nitrogen
on the 4-oxo-enal, the current duplex geometry allows for
subsequent Michael addition with formation of a bi- (in
case of C) or tricyclic (in case of A) structures, in a similar
process as described for cis-2-butene-1,4-dial,. This would
explain why stable adducts were observed in MS without
loss of H2O.
In some cases MALDI–TOF and RPHPLC spectra of
the isolated duplexes contained a second signal corre-
sponding to stable cross-linked duplexes that had lost
one molecule of H2O. We therefore propose that under
the acidic MALDI conditions, dehydration with concur-
rent aromatization of the structure (pathway c) is the most
probable pathway that explains the loss of water in this
second generation cross-linked duplexes. Adducts of this
last type have been isolated from reactions of the lipid
peroxidation product 4-oxo-2(E)-nonenal with free
nucleosides as well as those in dsDNA (39). Moreover
acid-catalysed rearrangement of the cis-2-utene-1,4-dial
adducts of 20-deoxyadenosine has been proven to give
rise to analogous tricyclic derivatives (40).
Remarkable in our case is the high stability of the
duplexes containing cross-links of the oxidized furan
moiety to adenine bases. In view of the much lower
reported stability of adducts of cis-2-butene-1,4-dial with
dA than with dC this is somewhat surprising (reported
half-lifes at pH 7.4 and 378C are 275h for adducts with
dC and only 6.1h for adducts with dA; see 41).
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Figure 7. RP–HPLC chromatogram after enzymatic degradation of duplex 11:20 CTGACGG2GTGC:GACTGCCCCACG. Enzymatic degradation
was performed using 200 units of Exo III for 0.6 nmol of puriﬁed cross-linked duplex. Digestions were carried out at 378C for 50min. Collected
fractions were analysed by MALDI–TOF MS. Products eluting at retention times below 10min correspond to short single-stranded fragments or
single nucleosides. See Supplementary Data for remaining degradation studies.
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Figure 8. C4-AP lesion generated by the action of bleomycin and con-
version into an oxo-enal.
1562 Nucleic Acids Research, 2009, Vol. 37,No. 5Presumably, the stability of the formed adducts is
enhanced in this intra-molecular duplex context.
As additional proof we decided to try and conﬁrm the
proposed cross-link structure by reacting protected inter-
mediary building block 7 with deoxycytidine under similar
conditions used for the duplex cross-linking. Protected
diol 7 was therefore treated with 1 eq. of NBS in a
THF–acetone–H2O mixture (Figure 10) after which 1 eq.
of deoxycytidine was added.
Puriﬁcation of the crude residue allowed isolation of a
product with a mass consistent with 32/33.
1H NMR spec-
tra allowed to completely structurally characterize the
obtained dimer. The product turned out to be a mixture
of 32 and a small amount of cyclized 33. It has been shown
that 3, N
4-ethenocytidine derivatives are ﬂuorescent in
their protonated state (42). Therefore the mixture consist-
ing of 32/33 was subjected to a 0.1M HCl treatment. In
this way an ethenocytidine derivative is generated (see acid
stable structure in Figure 9). Under these conditions a
clear ﬂuorescence emission maximum could be observed
at 433nm upon excitation at 360nm.
The yield of the cross-link reaction between the nucleo-
side building blocks was very low and isolation of the
desired adduct not easy which contrasts with the easy iso-
lation and high yields obtained in the crosslink reactions
with complementary oligonucleotides. Apparently the
proximity eﬀect and the pseudo-intra-molecularity have
a beneﬁcial inﬂuence on the inter-strand duplex ligation.
In the current methodology the requirement for
addition of NBS might limit applications in a biological
context. However, extensive research has been carried
out towards photo-oxidation of furan (43). In case of
monosubstituted furans, the initially generated endoper-
oxide has been shown to rearrange to an enal species,
similar to the one generated by NBS mediated oxidation
(44). The use of singlet-oxygen inducable cross-linking
oligonucleotides as adjuvants in photodynamic therapy
has been recently suggested (45). The singlet oxygen
induced cross-linking with furan-containing oligonucleo-
tides is currently under investigation and will be reported
upon in due course.
CONCLUSIONS
We have developed a new type of acyclic furan-containing
building block for incorporation in oligonucleotides and
subsequent inducible cross-linking. The new furan-
modiﬁed strands are capable of forming a strong and
selective cross-link with complementary strands in a
duplex upon addition of a selective oxidant, allowing con-
trol of the cross-link timing. The cross-link reaction is fast,
high-yielding and shows selectivity towards complemen-
tary adenine and cytosine. This selectivity was conﬁrmed
by enzymatic digestion with exonuclease III. Enzymatic
digestion experiments further proved that in general no
cross-linking to neighbouring bases was observed.
The cross-link enhances the stability of the duplex sig-
niﬁcantly in contrast to the non cross-linked modiﬁca-
tion which causes a strong destabilization of the duplex.
The obtained adducts resemble the naturally formed
mutagenic reaction products of cis-2-butene-1,4-dial,
a metabolite of the tobacco smoke and canned foods
contaminant furan. Furthermore, the generated keto-
aldehyde is structurally similar to C40-oxidized abasic
sites, commonly generated lesions by the antitumor
agent bleomycin.
In view of the diﬀerent selectivity results obtained
with the ﬁrst and the second generation building blocks,
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Figure 9. Possible mechanisms for formation of a covalent bond in the cross-link reaction.
Nucleic Acids Research,2009, Vol.37, No. 5 1563it is obvious that the modular nature of this furan-based
cross-linking strategy has allowed for optimization of
reactivity and selectivity of cross-link formation and
shows that possibly further ﬁne-tuning in terms of
yield and selectivity can be envisaged in the future. The
methodology thus lends itself ideally for the generation
of well-deﬁned and structurally characterized cross-
linked duplexes as models for cross-link repair studies.
Moreover the potential for singlet oxygen induced cross-
link formation should give access to the use of furan-
modiﬁed oligonucleotides in photodynamic therapy (46).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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